Alnylam Pharmaceuticals, Inc.
USD293.52
+2.15 (+0.74%)
CEO
Yvonne L. Greenstreet
IPO Date
2004-06-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$295.96
Prev. Close
$291.37
Day Low
$292.01
Day High
$295.96
52W Low
$273.11
52W High
$495.55
Market Cap
$39.19B
Volume
1.34M
| -108.0 |
| 31 Dec 2023 | FY | 83.0% | -24.1% | 199.5% | -11.5% | -5.92 | 3.08 | -54.3 |
| 31 Dec 2022 | FY | 83.7% | -109.0% | 714.9% | -31.9% | -8.34 | 3.51 | -25.6 |
| 31 Dec 2021 | FY | 83.4% | -101.0% | -145.0% | -23.4% | 1.70 | 4.04 | -23.6 |
| 31 Dec 2020 | FY | 84.2% | -174.1% | -84.5% | -25.2% | 0.51 | 4.47 | -17.4 |
| 31 Dec 2019 | FY | 88.6% | -403.2% | -61.6% | -37.0% | 0.21 | 4.87 | -14.2 |
| 31 Dec 2018 | FY | 97.6% | -1016.6% | -58.5% | -48.4% | 0.02 | 6.69 | -9.6 |
| 31 Dec 2017 | FY | 85.1% | -545.9% | -27.8% | -24.6% | 0.02 | 12.23 | -23.4 |
| 31 Dec 2016 | FY | 100.0% | -869.6% | -44.6% | -32.5% | 0.16 | 5.10 | -7.8 |
| 70.5 |
| 30 Sept 2025 | Q3 | 84.2% | 20.1% | 107.3% | 5.2% | 5.59 | 2.54 | 59.7 |
| 30 Jun 2025 | Q2 | 81.5% | -8.6% | -26.4% | -1.5% | 10.93 | 2.80 | -159.5 |
| 31 Mar 2025 | Q1 | 88.0% | -9.7% | -49.8% | -1.4% | 23.58 | 3.04 | -152.3 |
| 31 Dec 2024 | Q4 | 82.7% | -14.1% | -124.9% | -2.0% | 40.89 | 2.78 | -90.3 |
| 30 Sept 2024 | Q3 | 82.9% | -22.3% | -344.8% | -2.7% | 84.26 | 2.75 | -79.2 |
| 30 Jun 2024 | Q2 | 89.6% | -2.6% | 550.7% | -0.4% | -883.03 | 3.01 | -456.5 |
| 31 Mar 2024 | Q1 | 86.7% | -13.3% | 30.1% | -1.7% | -12.24 | 3.17 | -73.3 |
| 31 Dec 2023 | Q4 | 80.5% | -31.4% | 62.5% | -3.6% | -12.16 | 3.08 | -43.6 |